|
|
|
Insider
Information: |
Tang Capital Partners Lp |
Relationship: |
10% Owner |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
123,746 |
|
Indirect Shares
|
35,438,120 |
|
|
Direct
Value |
$28,512 |
|
|
Indirect Value
|
$73,539,576 |
|
|
Total
Shares |
35,561,866 |
|
|
Total
Value |
$73,568,089 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
1
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
11
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-4.3%
|
-74.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-15 |
4 |
B |
$3.52 |
$6,160 |
I/I |
1,750 |
803,155 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-16 |
4 |
B |
$3.52 |
$528 |
I/I |
150 |
803,305 |
1.42 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-19 |
4 |
B |
$3.52 |
$176 |
I/I |
50 |
803,355 |
1.42 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-21 |
4 |
B |
$3.57 |
$714,000 |
I/I |
200,000 |
1,003,355 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-12-27 |
4 |
B |
$4.07 |
$50,070 |
I/I |
12,300 |
103,294 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-12-28 |
4 |
B |
$4.32 |
$2,784,456 |
I/I |
644,968 |
196,294 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-03 |
4 |
B |
$4.21 |
$34,938 |
I/I |
8,300 |
1,581,129 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-04 |
4 |
B |
$4.33 |
$124,433 |
I/I |
28,732 |
1,609,861 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-05 |
4 |
B |
$4.50 |
$425,819 |
I/I |
94,700 |
1,704,561 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-06-11 |
4 |
OE |
$1.03 |
$440,217 |
I/I |
426,154 |
2,144,896 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-04 |
4 |
B |
$10.76 |
$601,021 |
I/I |
55,850 |
2,210,067 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-05 |
4 |
B |
$11.78 |
$459,330 |
I/I |
39,000 |
2,249,067 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-06 |
4 |
B |
$12.75 |
$178,500 |
I/I |
14,000 |
2,263,067 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-19 |
4 |
B |
$13.25 |
$499,936 |
I/I |
37,731 |
2,300,798 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
852,308 |
3,157,760 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-09-17 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,700 |
3,163,460 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-12-17 |
4 |
B |
$11.14 |
$1,745,103 |
I/I |
156,652 |
3,320,112 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2009-12-04 |
5 |
GD |
$0.00 |
$0 |
I/I |
129,242 |
67,052 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2010-11-15 |
5 |
GD |
$0.00 |
$0 |
I/I |
225,000 |
67,052 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2011-01-20 |
4 |
B |
$26.00 |
$5,512,000 |
I/I |
212,000 |
3,307,112 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2012-02-01 |
4 |
B |
$17.00 |
$7,249,990 |
I/I |
426,470 |
3,733,582 |
1.5 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-03 |
4 |
B |
$1.85 |
$34,249 |
I/I |
18,513 |
3,944,800 |
1.5 |
% |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-04 |
4 |
B |
$1.86 |
$193,888 |
I/I |
104,241 |
4,049,041 |
1.5 |
% |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-05 |
4 |
B |
$1.90 |
$319,806 |
I/I |
166,823 |
4,215,864 |
1.5 |
% |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-08 |
4 |
B |
$1.95 |
$111,292 |
I/I |
57,073 |
4,272,937 |
1.5 |
% |
|
176 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|